Morgan Stanley »

Axsome Therapeutics shares owned by Morgan Stanley

Quarter-by-quarter ownership of Axsome Therapeutics (AXSM) shares owned by Morgan Stanley from 13F filings

Historical chart of Morgan Stanley investment in Axsome Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Axsome Therapeutics held by Morgan Stanley consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Axsome Therapeutics by Morgan Stanley

Quarter filed Position value Share count Share price at filing
2023-09-30 $21M 298k 69.90
2023-06-30 $23M 323k 71.86
2022-12-31 $37M 477k 77.13
2022-06-30 $15M 392k 38.33
2022-03-31 $9.7M 231k 41.92
2021-06-30 $0 317k 0.00
2020-12-31 $0 49k 0.00
2020-09-30 $0 42k 0.00
2020-06-30 $0 46k 0.00
2020-03-31 $5.4M 92k 58.83
2019-12-31 $5.8M 56k 103.36
2019-09-30 $1.9M 92k 20.24
2019-03-31 $1.3M 91k 14.23
2018-12-31 $17k 6.0k 2.81
2018-09-30 $24k 7.0k 3.42
2018-06-30 $29k 9.0k 3.22
2018-03-31 $22k 9.0k 2.44
2017-12-31 $33k 5.9k 5.63
2017-03-31 $67k 17k 3.87
2016-12-31 $338k 50k 6.74
2016-09-30 $172k 22k 7.88
2016-06-30 $449k 60k 7.53
2016-03-31 $171k 20k 8.68
2015-12-31 $64k 6.9k 9.32